205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.07%
Revenue growth under 50% of QCOM's 15.83%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
6.28%
Gross profit growth under 50% of QCOM's 15.96%. Michael Burry would be concerned about a severe competitive disadvantage.
8.28%
EBIT growth below 50% of QCOM's 32.21%. Michael Burry would suspect deeper competitive or cost structure issues.
8.59%
Operating income growth under 50% of QCOM's 32.21%. Michael Burry would be concerned about deeper cost or sales issues.
9.81%
Net income growth under 50% of QCOM's 38.04%. Michael Burry would suspect the firm is falling well behind a key competitor.
9.48%
EPS growth under 50% of QCOM's 37.78%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
9.66%
Diluted EPS growth under 50% of QCOM's 38.42%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.11%
Share change of 0.11% while QCOM is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
No Data
No Data available this quarter, please select a different quarter.
12.62%
Dividend growth above 1.5x QCOM's 0.13%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
-2.92%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-44.64%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
73.70%
10Y revenue/share CAGR under 50% of QCOM's 237.84%. Michael Burry would suspect a lasting competitive disadvantage.
52.56%
5Y revenue/share CAGR at 50-75% of QCOM's 97.37%. Martin Whitman would worry about a lagging mid-term growth trajectory.
34.08%
3Y revenue/share CAGR under 50% of QCOM's 101.64%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
198.43%
Positive long-term OCF/share growth while QCOM is negative. John Neff would see a structural advantage in sustained cash generation.
83.17%
Positive OCF/share growth while QCOM is negative. John Neff might see a comparative advantage in operational cash viability.
13.33%
3Y OCF/share CAGR under 50% of QCOM's 409.59%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
782.06%
Net income/share CAGR above 1.5x QCOM's 294.74% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
120.11%
5Y net income/share CAGR similar to QCOM's 128.77%. Walter Schloss might see both on parallel mid-term trajectories.
77.97%
Below 50% of QCOM's 811.32%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
49.67%
Positive growth while QCOM is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
37.23%
Positive 5Y equity/share CAGR while QCOM is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
52.90%
Below 50% of QCOM's 1243.81%. Michael Burry suspects a serious short-term disadvantage in building book value.
576.51%
10Y dividend/share CAGR above 1.5x QCOM's 216.95%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
129.41%
5Y dividend/share CAGR above 1.5x QCOM's 28.39%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
48.82%
3Y dividend/share CAGR above 1.5x QCOM's 11.15%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
2.90%
AR growth is negative/stable vs. QCOM's 21.24%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
2.52%
Inventory growth well above QCOM's 3.03%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
6.03%
Similar asset growth to QCOM's 6.37%. Walter Schloss finds parallel expansions or investment rates.
9.61%
Under 50% of QCOM's 21.68%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
6.03%
Debt growth far above QCOM's 0.03%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
0.26%
R&D dropping or stable vs. QCOM's 0.75%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
-1.94%
We cut SG&A while QCOM invests at 3.69%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.